Wolters Kluwer NV (FRA:WOSB) Future Policy Benefits

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WOSB Wolters Kluwer NV FRA:WOSB
78 GF Score
Price €67.96
GF Value €154.52
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Wolters Kluwer NV Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.

FRA:WOSB
78GF Score
Wolters Kluwer NV FRA:WOSB
Future Policy Benefits is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Wolters Kluwer NV (FRA:WOSB) Overvalued in 2026?

Based on GuruFocus' analysis, Wolters Kluwer NV stock appears to be undervalued. The current stock price of €67.96 is trading 56% below its estimated GF Value™ of €154.52. GuruFocus considers Wolters Kluwer NV to be Significantly Undervalued.

Key valuation signals for FRA:WOSB:

  • Future Policy Benefits:
  • GF Value™: €154.52 vs. price of €67.96 (56% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the FRA:WOSB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wolters Kluwer NV Business Description

Address Zuidpoolsingel 2, P.O. Box 1030, Alphen aan den Rijn, ZH, NLD, 2400
Wolters Kluwer NV is a Dutch multinational provider of professional information, software, and services. It operates through divisions including Health, Tax & Accounting, Governance, Risk & Compliance, and Legal & Regulatory. Its products include clinical decision support tools such as UpToDate, tax and accounting software like CCH Axcess and TeamMate, compliance and risk management platforms, and legal research and workflow solutions. Customers are primarily professionals and institutions: hospitals and clinicians, accountants and tax advisors, law firms, banks, insurers, and corporate compliance and finance departments. Revenue is generated mainly through subscription and recurring software licenses, with additional transactional and service fees. North America accounts for the largest share of revenue, followed by Europe, with the remainder from Asia Pacific and other regions. The company is headquartered in Alphen aan den Rijn, Netherlands, and is listed on Euronext Amsterdam.
78GF Score

Get the complete analysis for FRA:WOSB

Future Policy Benefits is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€67.96
Price
€154.52
GF Value